Effects of Metreleptin in Type 1 Diabetes Mellitus
This study is currently recruiting participants.
Verified June 2012 by University of Texas Southwestern Medical Center
University of Texas Southwestern Medical Center
Juvenile Diabetes Research Foundation
Amylin Pharmaceuticals, LLC.
Information provided by (Responsible Party):
Abhimanyu Garg, University of Texas Southwestern Medical Center
First received: December 29, 2010
Last updated: June 12, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||February 2013|
|Estimated Primary Completion Date:||October 2012 (Final data collection date for primary outcome measure)|